Skip to content
10-Q

Quarterly Report

Nuo Therapeutics, Inc. AURX

0001437749-24-025952

← back to feed
Filed
Aug 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 12, 2024 45.47M sh
Cash And Equivalents Q2 2024 · Jun 30, 2024 $473.04K
Cash And Equivalents Q2 2024 · Dec 31, 2023 $928.68K
Cash And Equivalents Q2 2024 · Jun 30, 2023 $344.37K
Cash And Equivalents Q2 2024 · Dec 31, 2022 $2.05M
Current Liabilities Q2 2024 · Jun 30, 2024 $690.35K
Current Liabilities Q2 2024 · Dec 31, 2023 $674.53K
Total Liabilities Q2 2024 · Jun 30, 2024 $821.96K
Total Liabilities Q2 2024 · Dec 31, 2023 $838.73K
Current Assets Q2 2024 · Jun 30, 2024 $1.17M
Current Assets Q2 2024 · Dec 31, 2023 $1.56M
Total Assets Q2 2024 · Jun 30, 2024 $1.42M
Total Assets Q2 2024 · Dec 31, 2023 $1.88M
Capex Q2 2024 · Jun 30, 2023 $5.34K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$1.7M
Stockholders Equity Q2 2024 · Jun 30, 2023 $470.84K
Stockholders Equity Q2 2024 · Mar 31, 2023 $1.34M
Stockholders Equity Q2 2024 · Dec 31, 2022 $2.19M
Eps Basic Q2 2024 · Jun 30, 2023 −$0.02
Eps Basic Q2 2024 · Jun 30, 2023 −$0.04
Sga Expense Q2 2024 · Jun 30, 2023 $969.11K
Sga Expense Q2 2024 · Jun 30, 2023 $1.87M
Net Income Q2 2024 · Jun 30, 2023 −$871.89K
Net Income Q2 2024 · Jun 30, 2023 −$1.73M
Net Income Q2 2024 · Mar 31, 2023 −$855.76K
Operating Income Q2 2024 · Jun 30, 2023 −$871.42K
Operating Income Q2 2024 · Jun 30, 2023 −$1.73M
Gross Profit Q2 2024 · Jun 30, 2023 $97.68K
Gross Profit Q2 2024 · Jun 30, 2023 $148.36K